We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 551

Competition law scrutiny of patent settlements - a new focus in Australia?
  • DLA Piper LLP
  • Australia
  • November 15 2016

Settlement agreements in patent disputes between pharmaceutical companies may soon face greater competition law scrutiny in Australia. The


RK Health Insights 11 November 2016
  • Russell Kennedy
  • Australia
  • November 11 2016

Legislation passed in the Commonwealth Parliament has established a new National Cancer Screening Register aimed at saving lives through increased


Competition law scrutiny of patent settlements a new focus in Australia?
  • DLA Piper LLP
  • Australia
  • October 24 2016

Settlement agreements in patent disputes between pharmaceutical companies may soon face greater competition law scrutiny in Australia. The


Doing business in Australia: An introductory guide
  • PwC Australia
  • Australia, Global, OECD
  • October 20 2016

Australia is the world's sixth largest country, comprising an area of approximately 7.7 million square kilometres. It is a vast continent covering a


Doing Business in Australia
  • Baker & McKenzie
  • Australia, Global, Hong Kong, OECD, USA
  • September 7 2016

The Commonwealth of Australia comprises a federation of six States: New South Wales, Queensland, South Australia, Tasmania, Victoria and Western


AMA welcomes ACCC legal action against Medibank Private
  • Russell Kennedy
  • Australia
  • July 29 2016

The Australian Medical Association ("AMA") has welcomed the Australian Competition and Consumer Commission's ("ACCC") decision to commence legal


Misuse of market power: How proposed changes to the law will affect the private health insurance sector
  • DLA Piper LLP
  • Australia
  • April 6 2016

The Turnbull Government recently announced that it will adopt the Harper Review's recommendation to amend section 46 of the Competition and Consumer


Australian health sector remains under ACCC spotlight in 2016
  • DLA Piper LLP
  • Australia
  • March 17 2016

The Australian Competition and Consumer Commission (ACCC) recently released its enforcement priorities for 2016. Each year, the ACCC nominates its


Major trends give rise to competition concerns in the Australian life sciences sector
  • DLA Piper LLP
  • Australia
  • December 1 2015

Many of the global challenges encountered by the life sciences sector in recent years have emerged in Australia. Consistent with the global outlook


RK health insights 19 November 2015
  • Russell Kennedy
  • Australia
  • November 19 2015

The Federal Government is set to remove 17 common over-the-counter medicines (including paracetamol and aspirin) from the Pharmaceutical Benefits